Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3729109
Max Phase: Preclinical
Molecular Formula: C20H14F2N2O2S
Molecular Weight: 384.41
Molecule Type: Small molecule
Associated Items:
ID: ALA3729109
Max Phase: Preclinical
Molecular Formula: C20H14F2N2O2S
Molecular Weight: 384.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2c(C)noc2cc1-c1ccc(C(=O)Nc2c(F)cccc2F)s1
Standard InChI: InChI=1S/C20H14F2N2O2S/c1-10-8-13-11(2)24-26-16(13)9-12(10)17-6-7-18(27-17)20(25)23-19-14(21)4-3-5-15(19)22/h3-9H,1-2H3,(H,23,25)
Standard InChI Key: GFHBVTGLYOESLW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 384.41 | Molecular Weight (Monoisotopic): 384.0744 | AlogP: 5.70 | #Rotatable Bonds: 3 |
Polar Surface Area: 55.13 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.73 | CX Basic pKa: 0.34 | CX LogP: 4.94 | CX LogD: 4.94 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.49 | Np Likeness Score: -1.58 |
1. (2012) Compounds that modulate intracellular calcium, |
Source(1):